Abstract:Background and aim: Traumatic brain injury (TBI), a leading cause of high morbidity and mortality, represents a significant global public health challenge. Currently, no effective treatment for TBI exists. Curcumin, an active compound extracted from the root of Curcuma longa , has demonstrated neuroprotective properties both in vitro and in vivo . Notably, it has shown potential in reducing oxidative stress and inflammation and enhancing redox balance. This paper conducts a systematic review and meta-analysis to explore curcumin's role in TBI animal models extensively. The findings offer valuable insights for future human clinical trials evaluating curcumin as a therapeutic supplement or nutraceutical in TBI management. Methods: Comprehensive literature searches were conducted across MEDLINE, Embase, Cochrane, Web of Science, and Google Scholar databases. These searches aimed to identify relevant manuscripts in all languages, utilizing the keywords "curcumin" and "traumatic brain injury." Results: The final quantitative analysis included 18 eligible articles corresponding to animal studies. The analysis revealed that curcumin significantly reduced inflammatory cytokines, including IL-1β ( p = 0.000), IL-6 ( p = 0.002), and TNF-α ( p = 0.000), across various concentrations, time points, and administration routes. Additionally, curcumin markedly enhanced the activity of oxidative stress markers such as SOD ( p = 0.000), Sir2 ( p = 0.000), GPx ( p = 0.000), and Nrf2 ( p = 0.000), while reducing MDA ( p = 0.000), 4-HNE ( p = 0.001), and oxyprotein levels ( p = 0.024). Furthermore, curcumin improved cerebral edema ( p = 0.000) and upregulated neuroprotective factors like synapsin I ( p = 0.019), BDNF ( p = 0.000), and CREB ( p = 0.000), without reducing mNSS ( p = 0.144). About autophagy and apoptosis, curcumin increased the activity of Beclin-1 ( p = 0.000) and Bcl-2 ( p = 0.000), while decreasing caspase-3 ( p = 0.000), the apoptosis index ( p = 0.000), and P62 ( p = 0.002). Conclusion: Curcumin supplementation positively affects traumatic brain injury (TBI) by alleviating oxidative stress and inflammatory responses and promoting neuroprotection. It holds potential as a therapeutic agent for human TBI. However, this conclusion necessitates further substantiation through high-quality literature and additional randomized controlled trials (RCTs). Systematic Review Registration: https://www.crd.york.ac.uk/prospero/. The registration number of PROSPERO: CRD42023452685.

Curcumin Attenuates Acute Inflammatory Injury by Inhibiting the TLR4/MyD88/NF-κB Signaling Pathway in Experimental Traumatic Brain Injury

Curcumin Suppress Inflammatory Response in Traumatic Brain Injury Via P38/mapk Signaling Pathway.

Curcumin Provides Neuroprotection in Model of Traumatic Brain Injury Via the Nrf2-ARE Signaling Pathway

Curcumin Modulates TLR4/NF-κB Inflammatory Signaling Pathway Following Traumatic Spinal Cord Injury in Rats

Curcumin in the treatment of inflammation and oxidative stress responses in traumatic brain injury: a systematic review and meta-analysis

Disruption of Nrf2 Enhances Upregulation of Nuclear Factor-κB Activity, Proinflammatory Cytokines, and Intercellular Adhesion Molecule-1 in the Brain after Traumatic Brain Injury

Curcumin alleviates neuroinflammation, enhances hippocampal neurogenesis, and improves spatial memory after traumatic brain injury

Neuroprotective Effects of Resatorvid Against Traumatic Brain Injury in Rat: Involvement of Neuronal Autophagy and TLR4 Signaling Pathway

Tetrahydrocurcumin provides neuroprotection in rats after traumatic brain injury: autophagy and the PI3K/AKT pathways as a potential mechanism

TAK-242, a Toll-Like Receptor 4 Antagonist, Against Brain Injury by Alleviates Autophagy and Inflammation in Rats

Curcumin Mitigates Neuro-Inflammation by Modulating Microglia Polarization Through Inhibiting TLR4 Axis Signaling Pathway Following Experimental Subarachnoid Hemorrhage

Curcumin Reduces Brain-Infiltrating T Lymphocytes after Intracerebral Hemorrhage in Mice

A highly bioavailable curcumin formulation ameliorates inflammation cytokines and neurotrophic factors in mice with traumatic brain injury

Curcumin Inhibits the Increase of Labile Zinc and the Expression of Inflammatory Cytokines after Traumatic Spinal Cord Injury in Rats.

Curcumin mitigates axonal injury and neuronal cell apoptosis through the PERK/Nrf2 signaling pathway following diffuse axonal injury

Curcumin Inhibits Microglia Inflammation and Confers Neuroprotection in Intracerebral Hemorrhage

Hydroxychloroquine attenuates neuroinflammation following traumatic brain injury by regulating the TLR4/NF-κB signaling pathway

Curcumin alleviates traumatic brain injury induced by gas explosion through modulating gut microbiota and suppressing the LPS/TLR4/MyD88/NF-κB pathway

Tetrahydrocurcumin Reduces Oxidative Stress-Induced Apoptosis Via the Mitochondrial Apoptotic Pathway by Modulating Autophagy in Rats after Traumatic Brain Injury.

Resveratrol attenuates neuronal autophagy and inflammatory injury by inhibiting the TLR4/NF-κB signaling pathway in experimental traumatic brain injury

Tetrahydrocurcumin Protects Against GSK3β/PTEN/PI3K/Akt-Mediated Neuroinflammatory Responses and Microglial Polarization Following Traumatic Brain Injury